{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:20:07Z","timestamp":1791300007400,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/01.pra.0000388628.44405.c0","type":"journal-article","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T11:34:26Z","timestamp":1285068866000},"page":"334-339","source":"Crossref","is-referenced-by-count":29,"title":["CNS Drug Development: Part I: The Early Period of CNS Drugs"],"prefix":"10.1097","volume":"16","author":[{"given":"Sheldon H.","family":"Preskorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210210","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cber.188702001142","article-title":"Uber einige Derivate der Phenylmethacrylsaure und der Phenylisobuttersaure","volume":"20","author":"Edeleanu","year":"1887","journal-title":"Ber Deutsch Chem Ges"},{"key":"R2-6-20210210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ardp.18601530202","article-title":"Ueber eine neue organische Base in den Cocabl\u00e4ttern","volume":"153","author":"Niemann","year":"1860","journal-title":"Archiv der Pharmazie"},{"key":"R3-6-20210210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10401230591002002","article-title":"History of the discovery and clinical introduction of chlorpromazine","volume":"17","author":"Lopez-Munoz","year":"2005","journal-title":"Ann Clin Psychiatry"},{"key":"R5-6-20210210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.sapharm.2008.06.005","article-title":"Social reactions to Valium and Prozac: A cultural lag perspective of drug diffusion and adoption","volume":"5","author":"Marshall","year":"2009","journal-title":"Res Social Adm Pharm"},{"key":"R6-6-20210210","article-title":"Drug discovery: A casebook and analysis","author":"Maxwell","year":"2009"},{"key":"R7-6-20210210","first-page":"269","article-title":"Preliminary study of isocarboxazid, an iproniazid analog","volume":"20","author":"Darling","year":"1959","journal-title":"Dis Nerv Syst"},{"key":"R8-6-20210210","first-page":"521","article-title":"Lithium carbonate. A survey of the history and current status of lithium in treating mood disorders","volume":"32","author":"Prien","year":"1971","journal-title":"Dis Nerv Syst"},{"key":"R9-6-20210210","first-page":"171","article-title":"[History of opium poppy and morphine]","volume":"33","author":"Norn","year":"2005","journal-title":"Dan Medicinhist Arbog"},{"key":"R11-6-20210210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0031-6997(25)06712-2","article-title":"The biological fate of reserpine","volume":"28","author":"Stitzel","year":"1976","journal-title":"Pharmacol Rev"},{"key":"R12-6-20210210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.pra.0000281486.34817.8b","article-title":"The evolution of antipsychotic drug therapy: Reserpine, chlorpromazine, and haloperidol","volume":"13","author":"Preskorn","year":"2007","journal-title":"J Psychiatr Pract"},{"key":"R13-6-20210210","first-page":"453","article-title":"Adult psychopathology: A social work perspective","author":"Goodwin","year":"1982"},{"key":"R14-6-20210210","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3928\/0048-5713-19901101-06","article-title":"The future and psychopharmacology: Potentials and needs","volume":"20","author":"Preskorn","year":"1990","journal-title":"Psychiatr Ann"},{"key":"R15-6-20210210","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00131746-200011000-00006","article-title":"The stages of drug development and the human genome project: Drug discovery","volume":"6","author":"Preskorn","year":"2000","journal-title":"J Psychiatr Pract"},{"key":"R18-6-20210210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijantimicag.2008.06.001","article-title":"80th Anniversary of the discovery of penicillin An appreciation of Sir Alexander Fleming","volume":"32","author":"Geddes","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"R19-6-20210210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/ja.2008.16","article-title":"Microbial drug discovery: 80 years of progress","volume":"62","author":"Demain","year":"2009","journal-title":"J Antibiot (Tokyo)"},{"key":"R20-6-20210210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.spid.2004.02.001","article-title":"Penicillin: Its discovery and early development","volume":"15","author":"Ligon","year":"2004","journal-title":"Semin Pediatr Infect Dis"},{"key":"R22-6-20210210","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/201441a0","article-title":"Production of penicillin in the United States (1941\u20131946)","volume":"201","author":"Richards","year":"1964","journal-title":"Nature"},{"key":"R23-6-20210210","first-page":"110","article-title":"Marooned: Only one choice","volume":"4","author":"Preskorn","year":"1998","journal-title":"Journal of Practical Psychiatry and Behavioral Health"},{"key":"R24-6-20210210","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00131746-200009000-00008","article-title":"The human genome project and modern drug development in psychiatry","volume":"6","author":"Preskorn","year":"2000","journal-title":"J Psychiatr Pract"},{"key":"R25-6-20210210","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2174\/138161209788168001","article-title":"Monoaminergic neurotransmission: The history of the discovery of antidepressants from 1950s until today","volume":"15","author":"Lopez-Munoz","year":"2009","journal-title":"Curr Pharm Des"},{"key":"R26-6-20210210","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.socscimed.2008.01.047","article-title":"The creation of the concept of an antidepressant: An historical analysis","volume":"66","author":"Moncrieff","year":"2008","journal-title":"Soc Sci Med"},{"key":"R27-6-20210210","article-title":"Clinical pharmacology of selective serotonin reuptake inhibitors","author":"Preskorn","year":"1996"},{"issue":"7","key":"R28-6-20210210","first-page":"1","article-title":"Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: A roadmap","volume":"68","author":"Weiden","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R29-6-20210210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00131746-200105000-00007","article-title":"Antipsychotic drug development in the prehuman- genome era: A full circle","volume":"7","author":"Preskorn","year":"2001","journal-title":"J Psychiatr Pract"},{"key":"R30-6-20210210","first-page":"50","article-title":"Direct-to-consumer prescription drug advertising: History, regulation, and issues","volume":"93","author":"Huh","year":"2010","journal-title":"Minn Med"}],"container-title":["Journal of Psychiatric Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00131746-201009000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:39:43Z","timestamp":1740526783000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00131746-201009000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pra.0000388628.44405.c0","relation":{},"ISSN":["1538-1145"],"issn-type":[{"value":"1538-1145","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}